Hal Barron is Director at Juno Therapeutics, Inc. (JUNO). They have made 2 open-market trades across 2 companies since 2014, most recently 2026-06-05.
CIK 0001418677
2 open-market purchases totalling $17.4M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| QNT | 255,833 | $7.6M |
| JUNO | 3,780 | $329K |
| ALXA | 34,922 | $32K |
| Total | $8.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-08 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.